EPHA2 gene

Known as: EPHRIN RECEPTOR EphA2, ECK, EPITHELIAL CELL RECEPTOR PROTEIN-TYROSINE KINASE 
This gene plays a role in development and is upregulated in several breast carcinomas.
National Institutes of Health

Related topics

Related topics

6 relations

Narrower (1)

EPHA2 wt Allele
Ephrin Type-A Receptor 2, humanLigand BindingPhosphorylationReceptor Signaling
(More)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Epha2 is a Critical Oncogene in Melanoma
EphA2 is a member of the Eph family of receptor tyrosine kinases and is highly expressed in many aggressive cancer types… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy.
One arising challenge in the treatment of breast cancer is the development of therapeutic resistance to trastuzumab, an antibody… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
Overexpression of the receptor tyrosine kinase EPH receptor A2 (EphA2) is commonly observed in aggressive breast cancer and… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
EphA2 receptor tyrosine kinase is frequently overexpressed in different human cancers, suggesting that it may promote tumor… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2005
Highly Cited
2005
A conditional feedback loop regulates Ras activity through EphA2.
The EphA2 receptor tyrosine kinase is frequently overexpressed in many cancers, including 40% of breast cancers. Here, we show… (More)
Is this relevant?
Review
2005
Review
2005
EphA2 as a target for ovarian cancer therapy.
EphA2 is a receptor tyrosine kinase that is overexpressed by many human cancers, and is often associated with poor prognostic… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma
The EphA2 receptor tyrosine kinase is overexpressed in a variety of human cancers. We sought to characterize the role of EphA2 in… (More)
  • figure 2
  • figure 1
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Differential EphA2 epitope display on normal versus malignant cells.
The EphA2 receptor tyrosine kinase is overexpressed in many different types of human cancers where it functions as a powerful… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2001
Highly Cited
2001
EphA2 overexpression causes tumorigenesis of mammary epithelial cells.
Elevated levels of protein tyrosine phosphorylation contribute to a malignant phenotype, although the tyrosine kinases that are… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis
The p53 tumor suppressor protein is mutated in more than 50% of all human cancers, which makes the study of its functions and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?